Literature DB >> 23108097

TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors.

Rob J W Arts1, Leo A B Joosten, Jos W M van der Meer, Mihai G Netea.   

Abstract

TREM-1 is an important signaling receptor expressed on neutrophils and monocytes that plays an important role in systemic infections. Here, we review the intracellular signaling pathways that mediate the immunological effects of TREM-1. Because of the absence of signaling motifs, TREM-1 constitutively associates with DAP12 for induction of intracellular signals. After phosphorylation of DAP12, production of chemokines and cytokines is induced. Moreover, TREM-1 also modulates signaling pathways induced by known classes of PRRs, such as TLRs and NLRs. The exact mechanisms through which TREM-1 influences TLR and NLR pathways are still largely elusive.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108097     DOI: 10.1189/jlb.0312145

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  88 in total

1.  Silencing Triggering Receptors Expressed on Myeloid Cells-1 Impaired the Inflammatory Response to Oxidized Low-Density Lipoprotein in Macrophages.

Authors:  Houxuan Li; Feifei Hong; Shengbo Pan; Lang Lei; Fuhua Yan
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

2.  A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition.

Authors:  Valerie Cuvier; Ulrike Lorch; Stephan Witte; Aurelie Olivier; Sebastien Gibot; Isabelle Delor; Jean-Jacques Garaud; Marc Derive; Margarita Salcedo-Magguilli
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

3.  Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Authors:  Valérie Bardet; Orianne Wagner-Ballon; Julien Guy; Céline Morvan; Camille Debord; Franck Trimoreau; Emmanuel Benayoun; Nicolas Chapuis; Nicolas Freynet; Cédric Rossi; Stéphanie Mathis; Marie-Pierre Gourin; Andréa Toma; Marie C Béné; Jean Feuillard; Estelle Guérin
Journal:  Haematologica       Date:  2015-01-30       Impact factor: 9.941

4.  Significant association of TREM-1 with HMGB1, TLRs and RAGE in the pathogenesis of insulin resistance in obese diabetic populations.

Authors:  Saravanan Subramanian; Pradeep K Pallati; Poonam Sharma; Devendra K Agrawal; Kalyana C Nandipati
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

5.  TREM-1 as a potential therapeutic target in neonatal sepsis.

Authors:  Lei Qian; Xiao-Wen Weng; Wei Chen; Chang-Hong Sun; Jian Wu
Journal:  Int J Clin Exp Med       Date:  2014-07-15

6.  Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis.

Authors:  Naomi-Liza Denning; Monowar Aziz; Atsushi Murao; Steven D Gurien; Mahendar Ochani; Jose M Prince; Ping Wang
Journal:  JCI Insight       Date:  2020-03-12

7.  Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.

Authors:  Chao Du; Lijun Peng; Guanjun Kou; Peng Wang; Lin Lu; Yanqing Li
Journal:  Dig Dis Sci       Date:  2018-03-07       Impact factor: 3.199

8.  The cytotoxic type 3 secretion system 1 of Vibrio rewires host gene expression to subvert cell death and activate cell survival pathways.

Authors:  Nicole J De Nisco; Mohammed Kanchwala; Peng Li; Jessie Fernandez; Chao Xing; Kim Orth
Journal:  Sci Signal       Date:  2017-05-16       Impact factor: 8.192

9.  Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.

Authors:  Liang Dong; Yong Zhou; Zhao-Qiong Zhu; Tian Liu; Jia-Xi Duan; Jun Zhang; Ping Li; Bruce D Hammcok; Cha-Xiang Guan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

10.  Activation of the TREM-1 pathway in human monocytes by periodontal pathogens and oral commensal bacteria.

Authors:  M Varanat; E M Haase; J G Kay; F A Scannapieco
Journal:  Mol Oral Microbiol       Date:  2016-09-06       Impact factor: 3.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.